How to find Ozempic in stock near you
Reviewed by Raagini Yedidi, MD,
Written by Amelia Willson
Reviewed by Raagini Yedidi, MD,
Written by Amelia Willson
last updated: Nov 01, 2024
5 min read
Key takeaways
Drug shortages have affected Ozempic on an ongoing basis for the past few years.
At the time of publication, all of the dosage strengths of Ozempic are listed as available and should be in stock.
If Ozempic isn’t in stock at your pharmacy, consider trying other local or online pharmacies, calling ahead to refill your prescription, or getting a two- or three-month supply.
You can also talk to your healthcare provider about Ozempic alternatives, including other injectable GLP-1 medications, prescription weight loss pills, compounded semaglutide, or Rybelsus.
Here's what we'll cover
Here's what we'll cover
Key takeaways
Drug shortages have affected Ozempic on an ongoing basis for the past few years.
At the time of publication, all of the dosage strengths of Ozempic are listed as available and should be in stock.
If Ozempic isn’t in stock at your pharmacy, consider trying other local or online pharmacies, calling ahead to refill your prescription, or getting a two- or three-month supply.
You can also talk to your healthcare provider about Ozempic alternatives, including other injectable GLP-1 medications, prescription weight loss pills, compounded semaglutide, or Rybelsus.
Whether you’ve seen the countless headlines or experienced the frustration firsthand, you’re likely well aware that an oft-asked question amongst patients is, “is Ozempic in stock?”
While Ozempic (semaglutide) faces shortages from time to time, this issue is not unique to this medication in particular. Recently, drug shortages across the board have reached their highest point in the last 10 years. But you’re here to find out whether Ozempic is in stock and how to be prepared if (or, dare we say, when) it experiences another shortage.
Read on as we share the latest on Ozempic’s availability and offer tips for finding Ozempic in stock near you.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Is Ozempic out of stock?
At the time of publication, semaglutide (the active ingredient in Ozempic) is categorized as “currently in shortage” while the individual dosage strengths of Ozempic are listed as “available,” according to the Drug Shortages database managed by the US Food and Drug Administration (FDA).
So, is Ozempic out of stock? It doesn’t seem to be. And the same can be said of Wegovy, which also contains semaglutide.
Not only do they contain semaglutide, but both Wegovy and Ozempic are also made by the same manufacturer, Novo Nordisk. Where the two medications differ is in their dosage strengths and FDA-approved indications.
Ozempic is intended for people with type 2 diabetes and helps lower blood sugar levels when used in combination with diet and exercise. It can also be prescribed to reduce the risk of heart attack, stroke, or death in people with type 2 diabetes and heart disease.
Wegovy is intended for people with obesity and overweight and helps with weight loss and weight management. It also was recently FDA-approved to reduce cardiovascular risk in people who have both heart disease and obesity or overweight.
Both drugs have experienced shortages since 2022. Because Ozempic can also produce weight loss—although to a lesser extent than Wegovy—it may be prescribed off-label for this purpose. Since both drugs contain the same active ingredient and can lead to weight loss, it is not uncommon for a Wegovy shortage to impact Ozempic’s availability and vice versa. Add to that the fact that Wegovy can now be prescribed for reducing heart attack and stroke, further increasing demand on an already strained supply.
Novo Nordisk has responded with a $6 billion plan to ramp up production, ABC News reported in May 2024. At this time, the drug maker was in the process of acquiring three additional production facilities and has already increased production fourfold since last year. Even so, given the unabated demand for both medications, the company still expects the shortages to continue as demand outpaces supply.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
When will Ozempic be back in stock?
As mentioned above, all dosage strengths of the medication are currently available at the time of publication. That being said, if you’re ever wondering whether Ozempic is in stock, you can search for “semaglutide” on the FDA’s Drug Shortages website.
As for Wegovy, all five strengths of the drug—0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg/0.75 mL—are also currently in stock, per the FDA.
Is it hard to get Ozempic?
Ozempic can be difficult to get for a few reasons. For one thing, Ozempic is expensive, and is listed at $968.52 for a monthly supply, though prices can vary. It also runs into supply issues fairly often, so it may be out of stock at pharmacies in your area. Plus, one strategy manufacturers may employ during times of a shortage is to prioritize use of the drug for certain patient populations. Novo Nordisk has previously taken this approach to combat the previous Wegovy shortage, by limiting distribution of the lower dosage strengths (which are usually prescribed to new patients) in order to focus production on the higher strengths and ensure adequate supply for existing Wegovy patients.
If you are considering switching to Ozempic due to, say, another drug shortage, know that it can be difficult to get insurance coverage if you don’t have diabetes or prediabetes. Your healthcare provider may still prescribe Ozempic off-label to you for weight loss, but since weight loss is not a FDA-approved indication, you may have to pay full price. If you are taking Ozempic off-label for weight loss, Wegovy may be an alternative option—and, depending on your insurance coverage, it may be more affordable. Wegovy is available in higher dosage strengths and has shown to lead to more weight loss than Ozempic. However, it does have a longer list of side effects, so you’ll want to talk to your healthcare provider about your options and the best treatment plan for you.
How to find Ozempic in stock near you
If you’re having trouble filling your prescription for Ozempic, read on. Here are five tips for finding Ozempic in stock near you.
1. Call around to local pharmacies
Sometimes your pharmacy may be out of stock of Ozempic. When that happens, call around to other local pharmacies in your area. Make sure to have your prescription on hand so you can inquire about your exact dosage.
Depending on the pharmacy, you may be able to get your prescription delivered to your home. If that’s the case, you may be able to expand your search radius even larger.
2. Try online pharmacies and tools
Another option is to order your Ozempic prescription through an online pharmacy. Often, these pharmacies offer free shipping to your home. You can also try a weight loss program, such as Ro Body, which offers personalized coaching, a prescription for a GLP-1 medication (if appropriate), and a health insurance concierge that helps with securing coverage.
Ro’s GLP-1 Supply Tracker, which is free and accessible to all (read: not just Ro patients), can also be helpful if you're struggling to find Ozempic in stock. The tool helps patients find GLP-1 supply, report shortages to the FDA, and track which drugs are currently in stock or shortage—plus, it can send you alerts when supply becomes available nearby.
3. Order ahead
The best way to sidestep a medication shortage is to order as soon as you can—maybe even way ahead, when it comes to Ozempic. If you normally call to refill your prescription a week before it’s due, bump that up to two weeks before, or even three, so they can prepare in advance.
4. Ask about three-month supplies
The default prescription for Ozempic is a month supply. But, two- and three-month supplies may also be available, depending on the pharmacy. Plus, if you’re already using the Ozempic Savings Card, we have good news: it applies to two- and three-month supplies as well.
5. Consider Ozempic alternatives
When all else fails, it may be time to talk to your health provider about Ozempic alternatives. Ozempic belongs to a class of drugs called GLP-1 medications. Some of these are FDA-approved to treat type 2 diabetes (and/or lower cardiovascular risk in people with type 2 diabetes), and some of them are FDA-approved for weight loss. During times of an Ozempic shortage, healthcare providers may recommend switching to another one of these medications.
For type 2 diabetes, alternative FDA-approved GLP-1 medications include:
For weight loss, other FDA-approved GLP-1 options include:
Like Ozempic, these are also injectable medications. However, at the time of publication, only Saxenda and Victoza are experiencing shortages in one or more dosage strengths and will continue to have limited availability until “TBD,” according to the FDA.
If you are taking Ozempic off-label for weight loss, prescription weight loss pills may be another suitable treatment option depending on conversation with your healthcare provider. These include Qsymia (phentermine/topiramate), Contrave (naltrexone/bupropion), and Xenical (orlistat). At the time of publication, all of these medications are currently available, according to the FDA Drug Shortages website.
Lastly, you may ask your healthcare provider about compounded semaglutide or Rybelsus, which contains the same active ingredient as Ozempic (semaglutide), and is also approved to treat type 2 diabetes. Rybelsus is available in different dosage strengths than Ozempic and is taken orally once a day, before your first meal in the morning. Decreased appetite is a common side effect of Rybelsus and modest weight loss is typical on the medication. In clinical trials, people lost around 8 pounds in about 6 months. And, happily, Rybelsus is not currently in shortage.
Drug shortages can be frustrating to deal with, but there are steps you can take to get back control of your treatment plan. Plan ahead for refilling your Ozempic prescription, and talk to your healthcare provider about your concerns.
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Saxenda Important Safety Information: Read more about serious warnings and safety info.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
American Society of Health-System Pharmacists. (2018). ASHP Guidelines on Managing Drug Product Shortages. Retrieved from https://www.ashp.org/-/media/assets/policy-guidelines/docs/guidelines/managing-drug-product-shortages.ashx
Collins, L. & Costello, R. A. (2023). Glucagon-Like Peptide-1 Receptor Agonists. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK551568/
Khera, R., Murad, M. H., Chandar, A. K., et al. (2016). Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA, 315(22), 2424–2434. doi: 10.1001/jama.2016.7602. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617638/
Kindelan, K. (2024). Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages. ABC News. Retrieved from https://abcnews.go.com/GMA/Wellness/novo-nordisk-announces-6b-investment-ozempic-wegovy-amid/story?id=109869113
National Association of Boards of Pharmacy. (2023). Diabetes Drug Shortages and Fake Ozempic. National Association of Boards of Pharmacy. Retrieved from https://nabp.pharmacy/news/blog/diabetes-drug-shortages-and-fake-ozempic/
NovoCare. (2023). Ozempic® (semaglutide) injection 0.5 mg, 1 mg, 2 mg List Price & Insurance Coverage Explained | NovoCare®. Novo Nordisk. Retrieved from https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html
Novo Nordisk. (2023). Ozempic® Savings Card | Ozempic® (semaglutide) injection. Retrieved on May 2, 2024 from https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
Novo Nordisk-a. (2024). Supply update. Retrieved from https://www.novonordisk-us.com/supply-update.html
Novo Nordisk-b. (2024). Wegovy® approved in the US for cardiovascular risk reduction in people with overweight or obesity and established cardiovascular disease. Retrieved on May 2, 2024 from https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=167030
Pagliarulo, N. (2023). Novo takes aim at obesity drug shortages with $6B manufacturing plan. Manufacturing Dive. Retrieved from https://www.manufacturingdive.com/news/novo-nordisk-manufacturing-glp-1-kalundborg-denmark/699551/
Robledo, A. (2024). Drug shortages at highest since 2014: Chemo drugs, Wegovy, ADHD medications affected. USA Today. Retrieved from https://www.usatoday.com/story/news/nation/2024/04/17/drug-shortages-2024-record-high/73361588007/
Singh, G., Krauthamer, M., & Bjalme-Evans, M. (2022). Wegovy (semaglutide): a new weight loss drug for chronic weight management. Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research, 70(1), 5–13. doi: 10.1136/jim-2021-001952. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717485/
U.S. Food and Drug Administration (FDA-a). (2024). FDA Drug Shortages: Semaglutide Injection. Retrieved from https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st=c
U.S. Food and Drug Administration (FDA). (2023). Highlights of Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s020s021lbl.pdf
U.S. Food and Drug Administration (FDA). (2022). Highlights of Prescribing Information: Rybelsus (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213051s011lbl.pdf
U.S. Food and Drug Administration (FDA-b). (2024). Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s011lbl.pdf